[Insterstitial brachytherapy of localised prostate cancer using iodine 125 permanent implants].
Brachytherapy with permanent implants is a validated method of treatment of prostate adenocarcinomas of favourable prognosis. Its technology is based on endorectal ultrasonography and on peroperative visualisation of the implant and the dose distribution. A strict selection of the patients is necessary before this localised treatment. An active collaboration between urologists, radiophysicists and radiation oncologists is necessary during all the process of selection, treatment and follow-up of the patients. An assessment of the carcinologic and functional results is necessary. Recommendations are formalized by a joint collaboration between members of the AFU and of the SFRO.
Peiffert
Didier
D
Unité de curiethérapie, centre Alexis-Vautrin, 54500 Vandoeuvre-Lès-Nancy cedex, France. d.peiffert@nancy.fnclcc.fr
D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy*; D001918:Brachytherapy / Q000379:methods*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D018084:Ultrasonography, Interventional
D007457:Iodine Radioisotopes